首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1566212

肉毒桿菌毒素市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Botulinum Toxin Market Size, Share, Growth Analysis, By Product (Type A, Type B), By Application (Aesthetic, Therapeutic), By End User (Hospitals, Dermatology Clinics), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月06日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球肉毒桿菌毒素市場規模將為100.1億美元，預測期間（2024-2031年）複合年成長率為9.83%，從2023年的111.2億美元成長至235.4億美元。

由於旨在將治療應用擴展到目前用途之外的研究和開發的進步，以及對美容和非侵入性手術的需求不斷增加，全球肉毒桿菌（BNT）市場預計將出現顯著成長。七种血清型的著名產品包括有限種類的 BNT-A 和單一產品 BNT-B，凸顯了市場多元化和創新的潛力。新產品推出的趨勢，加上患者負擔能力的提高和不斷變化的報銷政策（包括肉毒桿菌注射的保險範圍）進一步支持了這一成長。由於消費者對美容療程的興趣顯著增加，美國肉毒桿菌毒素市場預計將在未來的預測期內實現持續的複合年成長率。公司在研發方面的策略性投資將加強產品系列，並導致肉毒桿菌毒素在美容和治療領域中得到更廣泛的接受。總體而言，這些因素的結合使肉毒毒素市場成為醫療保健產業中充滿活力的細分市場，前景看好。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Ipsen Group
Allergan Inc.
Medy-Tox, Inc.
Metabiologics
Merz Pharma
Supernus Pharmaceutical
Evolus
Galderma
Lanzhou Institute of Biological Products
Revance Therapeutics
Hugel
Suneva Medical
Daewoong Pharmaceutical
Mylan
Teijin Pharma
Eisai
Prollenium Medical

簡介目錄

Product Code: SQMIG35I2220

Global Botulinum Toxin Market size was valued at USD 10.01 billion in 2022 and is poised to grow from USD 11.12 billion in 2023 to USD 23.54 billion by 2031, growing at a CAGR of 9.83% during the forecast period (2024-2031).

The global botulinum toxin (BNT) market is poised for significant growth, driven by increasing demand for cosmetic and non-invasive procedures, alongside advancements in research and development aimed at expanding therapeutic applications beyond its current uses. Comprising seven antigenic forms, notable products include a limited array of BNT-A and a singular BNT-B offering, underscoring the potential for market diversification and innovation. The trend towards new product launches, coupled with improving patient affordability and evolving reimbursement policies that now include coverage for botulinum injections, further propels this growth. With a notable increase in consumer interest in aesthetic treatments, the U.S. market for botulinum toxin is expected to experience a sustainable compound annual growth rate (CAGR) in the forthcoming forecast period. As companies invest strategically in R&D, this will enhance the product portfolio and encourage broader acceptance of botulinum toxin in both cosmetic and therapeutic domains. Overall, the confluence of these factors suggests a promising trajectory ahead for the botulinum toxin market, positioning it as a dynamic segment within the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Botulinum Toxin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Botulinum Toxin Market Segmental Analysis

Global Botulinum Toxin Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Type A (Botox, Dysport, Xeomin, Others), Type B. Based on Application, the market is segmented into Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others), Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others). Based on End User, the market is segmented into Hospitals, Dermatology Clinics, Cosmetic Centers and Medspas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Botulinum Toxin Market

The increasing demand for minimally invasive cosmetic procedures is a significant market driver for the global botulinum toxin market. As more individuals seek non-surgical options to achieve youthful appearances with minimal recovery time, botulinum toxin treatments have become increasingly popular for reducing wrinkles and fine lines. This trend is further fueled by a growing awareness of the benefits of aesthetic procedures, enhanced by social media influence and celebrity endorsements. Additionally, advancements in technology and product formulations have improved the effectiveness and safety of botulinum toxin therapies, thereby expanding their application in both cosmetic and therapeutic settings, propelling market growth.

Restraints in the Global Botulinum Toxin Market

The global botulinum toxin market may face significant restraints due to the potential side effects associated with its use. Adverse reactions, including muscle weakness, allergic reactions, and localized pain, can deter patients from seeking treatments, thus impacting market growth. Additionally, the perception of safety risks can influence healthcare professionals' recommendations, further complicating patient acceptance. Regulatory scrutiny surrounding the approval and marketing of botulinum toxin products may also pose challenges, as companies must navigate stringent guidelines while addressing concerns related to side effects. The cumulative effect of these factors could inhibit the expansion of the market and limit its overall potential.

Market Trends of the Global Botulinum Toxin Market

The global botulinum toxin market is witnessing significant growth, driven predominantly by cosmetic procedures favored by women, who constitute a remarkable 92% of all treatments. With a rising number of individuals over 40 prioritizing their physical appearance, especially in developed nations, the demand for aesthetics enhancements continues to surge. This trend is emphasized by the remarkable statistic of over 2.5 million women aged 40-54 undergoing botulinum toxin procedures in 2020 alone. As societal norms around beauty evolve, this market trend indicates robust prospects for botulinum toxin, with a sustained focus on anti-aging solutions likely to propel its expansion well into the future.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
PESTEL Analysis
Technology Analysis
Regulatory Landscape

Botulinum Toxin Market, By Product

Market Overview
Type A
- Botox
- Dysport
- Xeomin
- Others
Type B

Botulinum Toxin Market, By Application

Market Overview
Therapeutic
- Chronic Migraine
- Overactive Bladder
- Cervical Dystonia
- Spasticity
- Others
Aesthetic
- Glabellar Lines
- Crow's Feet
- Forehead Lines
- Others

Botulinum Toxin Market, By End User

Market Overview
Hospitals
Dermatology Clinics
Cosmetic Centers and Medspas

Botulinum Toxin Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Ipsen Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medy-Tox, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metabiologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Supernus Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evolus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galderma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lanzhou Institute of Biological Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revance Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hugel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Suneva Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daewoong Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teijin Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eisai
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prollenium Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments